Clinical Trial Update: Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm Labor [Phase 2]

View source ↗

Summary

Phase 2 trial suggests that docosahexaenoic acid (DHA) supplementation during pregnancy reduces the risk of preterm birth in women with threatened preterm labor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth
• Threatened Preterm Labor

Drugs mentioned

• Docosahexaenoic acid (DHA) supplement (docosahexaenoic acid)

Snippet

Sponsor: Khon Kaen University | Conditions: Pregnant Women Diagnosed With Threatened Preterm Labor | Phase 2 | Status: COMPLETED